We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$752M
AUM Growth
+$110M
Cap. Flow
+$81.1M
Cap. Flow %
10.79%
Top 10 Hldgs %
40.28%
Holding
184
New
49
Increased
34
Reduced
33
Closed
54

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$17.2M
2
ORCL icon
Oracle
ORCL
+$13.2M
3
ZBH icon
Zimmer Biomet
ZBH
+$12.5M
4
NGD
New Gold Inc
NGD
+$10.2M
5
INCY icon
Incyte
INCY
+$9.49M

Sector Composition

Rank Sector Weight
1 Healthcare 17.31%
2 Technology 13.37%
3 Materials 7.6%
4 Utilities 6.6%
5 Industrials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDP
51
DELISTED
Hortonworks, Inc.
HDP
$4.58M 0.61%
+270,000
New +$4.07M
MBII
52
DELISTED
Marrone Bio Innovations, Inc.
MBII
$4.23M 0.56%
3,681,580
FLXN
53
DELISTED
Flexion Therapeutics, Inc.
FLXN
$4.23M 0.56%
175,000
+10,000
+6% +$235K
SSNI
54
DELISTED
Silver Spring Networks, Inc.
SSNI
$3.98M 0.53%
246,000
-1,018,000
-81% -$12.8M
FSLR icon
55
PUT
First Solar
FSLR
$21.4B
$3.9M 0.52%
+85,000
New +$3.94M
EVA
56
DELISTED
Enviva Inc.
EVA
$3.63M 0.48%
122,739
+5,000
+4% +$144K
AIOT
57
PowerFleet Inc
AIOT
$537M
$3.59M 0.48%
478,301
+214,280
+81% +$1.41M
GSM icon
58
FerroAtlántica
GSM
$590M
$3.55M 0.47%
270,000
-325,000
-55% -$4.22M
WOLF icon
59
Wolfspeed
WOLF
$1.04B
$3.03M 0.4%
107,500
+32,500
+43% +$809K
IBM icon
60
CALL
IBM
IBM
$213B
$2.9M 0.39%
20,920
VRTX icon
61
Vertex Pharmaceuticals
VRTX
$123B
$2.81M 0.37%
+18,500
New +$2.78M
NYRT
62
DELISTED
New York REIT, Inc.
NYRT
$2.75M 0.37%
+35,000
New +$2.91M
UUP icon
63
Invesco DB US Dollar Index Bullish Fund
UUP
$423M
$2.42M 0.32%
+100,000
New +$2.42M
SHPG
64
DELISTED
Shire pic
SHPG
$2.07M 0.27%
13,500
+6,500
+93% +$1.02M
GILD icon
65
CALL
Gilead Sciences
GILD
$165B
$2.03M 0.27%
25,000
-100,000
-80% -$7.65M
RUN icon
66
Sunrun
RUN
$2.26B
$2.03M 0.27%
365,000
-35,000
-9% -$239K
VTNR
67
DELISTED
Vertex Energy, Inc
VTNR
$1.96M 0.26%
+1,574,021
New +$1.44M
AMZN icon
68
Amazon
AMZN
$2.44T
$1.94M 0.26%
+40,300
New +$1.98M
GOOG icon
69
Alphabet (Google) Class C
GOOG
$4.11T
$1.82M 0.24%
38,000
-182,000
-83% -$8.48M
CSIQ icon
70
CALL
Canadian Solar
CSIQ
$932M
$1.68M 0.22%
100,000
IBB icon
71
iShares Biotechnology ETF
IBB
$9.45B
$1.5M 0.2%
13,500
-1,500
-10% -$160K
CELG
72
DELISTED
Celgene Corp
CELG
$1.46M 0.19%
10,000
-126,000
-93% -$17.2M
AET
73
DELISTED
Aetna Inc
AET
$1.11M 0.15%
7,000
+1,000
+17% +$156K
NBIS
74
Nebius Group N.V.
NBIS
$37.6B
$989K 0.13%
+30,000
New +$916K
TEVA icon
75
CALL
Teva Pharmaceuticals
TEVA
$40.4B
$880K 0.12%
50,000

Similar funds

Ardsley Advisory Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Ardsley Advisory Partners held 184 positions worth $752M, up 17% from $642M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Ardsley Advisory Partners deployed $81.1M of net new capital in Q3 2017, opening 49 new positions and adding to 34 existing holdings. Its largest new stake was Centene: 400,000 shares worth $19.4M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 12% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Celgene Corp, an estimated $17.2M trimmed.

  • Ardsley Advisory Partners's largest Q3 2017 buy was Centene: 400,000 shares worth $19.4M.
  • Ardsley Advisory Partners added most to Zimmer Biomet in Q3 2017, an estimated $12.5M increase.
  • Ardsley Advisory Partners's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $17.2M.
  • Ardsley Advisory Partners fully exited Bluerock Residential Growth REIT, Inc. in Q3 2017, selling an estimated $8.05M.
  • Ardsley Advisory Partners's ten largest holdings make up 40% of its $752M portfolio in Q3 2017.
  • Ardsley Advisory Partners opened 49 new positions and closed 54 in Q3 2017.
  • Ardsley Advisory Partners's portfolio value rose 17% quarter-over-quarter to $752M.

Based on Ardsley Advisory Partners's 13F filing for Q3 2017, filed 14 Nov 2017.